Functional Forum Live from San Francisco
9 hours ago
- SUPAR may represent a next-generation biomarker for systemic chronic inflammation, enabling earlier detection of chronic disease risk across multiple organ systems.
- A precision functional medicine trial showed significant improvement in mild cognitive impairment and dementia outcomes compared to standard care, suggesting potential reversibility.
- Emerging research links chronic disease to biological and psychosocial drivers including loneliness, trauma imprinting, and cellular stress responses that may be modifiable through targeted interventions.
Comments